Skip to main content
Formulas

Energy

RA·NUE has two energy formulas. MitoCore is Super NAD+, NAD+ with NRC in a 700 mg enteric-coated capsule; its label claims cellular energy support and oral NAD+ absorption support. Foundation Prime is Vitamax Regener8, an 803 mg blend taken four capsules a day, which claims elevated daily vitality.

A woman in a navy jacket jogs a gravel path beside a reservoir at sunrise, her breath visible, gold light on the still water.

Who it is for

People who want the energy formula to be simple, which is MitoCore with 2 ingredients, or who want a broad daily formula and do not mind a four-capsule routine, which is Foundation Prime.

The formulas

  • MitoCore

    Super NAD+ · 60 count

    • Supports Cellular Energy

    The label also claims immune function and lymphatic function support.

    • $99.95
    • $1.67 a serving

  • Foundation Prime

    Vitamax Regener8 · 60 count

    • Promotes Elevated Daily Vitality

    NAD+, NRC/NMN, CoQ10 and B vitamins are among 43 ingredients on the panel.

    • $89.95
    • $1.50 a serving

How to take them

MitoCore. One or two capsules a day at any hour, swallowed or opened into a drink. No more than three.

Foundation Prime. Eat 300 to 400 calories with fat first, then two capsules in the morning and two more around 3pm or an hour and a half after dinner.

MitoCore. Directions: Take 1-2 capsules daily or add 1-2 capsules into your favorite beverage. Do not exceed more than 3 capsules per day and please consult your healthcare provider before taking this product.

Foundation Prime. Directions: Take 2 capsules in the am and 2 capsules around 3pm or 2 caps 1.5 hours after eating dinner. Eat 300-400 hundred calories with high fat content prior to taking our products. Please consult your healthcare provider before taking this product.

Directions, as the labels print them.

Before you start

Foundation Prime’s label says not to take it if you use an SSRI, and its chitosan comes from shellfish. Both labels ask you to consult a physician if you take medication or have a medical condition, and not to use them while pregnant or nursing.

MitoCore. Warnings: Do not use if safety seal is broken or missing. Not recommend for pregnant/nursing women. Consult a physician if taking medication or have a medical condition. Keep out of reach of children. Store in a cool, dry place after opening. Never exceed the recommended dose.

Foundation Prime. Warnings: Do not use if safety seal is broken or missing. Not recommended for pregnant/nursing women. Consult a physician if taking medication (including insulin and oral diabetic medications), or have a medical condition. Keep out of reach of children. Store in a cool, dry place after opening. Never exceed the recommended dose. Warning: Do not take this product if currently using SSRI medication.

Foundation Prime. Allergen Advisory: Chitosan is derived from shellfish. Individuals with shellfish allergies should avoid this product. Although highly purified, trace amounts of allergenic proteins may be present. Discontinue use immediately if any adverse reaction occurs.

Warnings, as the labels print them.

Prescription peptides

Injectable NAD+ is a prescription product that only a licensed provider can decide on. RA·NUE’s prescription path is not open.

What peptides are, and where the rules stand

Questions

Does NAD+ survive being swallowed?

Absorption is what the MitoCore label addresses. It claims oral NAD+ absorption support, and the capsule is enteric-coated so it opens past the stomach.

Which has fewer ingredients?

MitoCore, with 2: NAD+ and NRC. Foundation Prime lists 43.

Can I put MitoCore in coffee or a smoothie?

The label allows adding one or two capsules to your favorite beverage.

Why does Foundation Prime need food with fat?

The label asks for 300 to 400 calories with high fat content before each dose. It does not say why, and we will not guess.

Is either one a stimulant?

Neither label calls itself one. Foundation Prime’s panel lists green tea extract, so check the panel if you avoid caffeine sources.

Sources